Discussion In recent years, the incidence of osteomyelitis in clinical practice has shown an increasing trend (Zhang et al. 2022 ).
← all excerpts
Potential risk signals for drug-related osteomyelitis: a comprehensive disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database.
1
—
—